ArticleJournal of diabetes investigation2024

Sodium-glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes.

Shujun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.